首页 | 本学科首页   官方微博 | 高级检索  
     

CYPHER药物洗脱支架治疗支架内再狭窄的临床疗效
引用本文:刘海潮,刘映峰,李志樑,李公信,魏向荣,傅强,赵霞,王同汉. CYPHER药物洗脱支架治疗支架内再狭窄的临床疗效[J]. 中国循环杂志, 2004, 19(3): 178-179
作者姓名:刘海潮  刘映峰  李志樑  李公信  魏向荣  傅强  赵霞  王同汉
作者单位:510280,广东省广州市,中国人民解放军第一军医大学珠江医院,心内科
摘    要:
目的:探讨CYPHER药物洗脱支架治疗支架内再狭窄的经验及临床疗效.方法:9例支架内再狭窄患者接受了12枚CYPHER药物洗脱支架治疗,其中右冠状动脉病变4例,前降支病变7例,左旋支病变1例.结果:12处支架内再狭窄病变均成功放置药物支架,手术成功率100%.所有患者临床症状明显改善,无并发症发生.所有患者于术后6个月复查冠状动脉造影,无一例发生再狭窄.结论:CYPHER药物洗脱支架治疗支架内再狭窄安全、有效、可行.

关 键 词:支架  再狭窄  药物洗脱支架  雷帕霉素
文章编号:1000-3614(2004)03-0178-02
修稿时间:2003-12-29

Rapamycin-Eluting Stents for the Treatment of In-Stent Restenosis
Liu Haichao,Liu Yingfeng,Li Zhiliang,et al.. Rapamycin-Eluting Stents for the Treatment of In-Stent Restenosis[J]. Chinese Circulation Journal, 2004, 19(3): 178-179
Authors:Liu Haichao  Liu Yingfeng  Li Zhiliang  et al.
Abstract:
Objective: To investigate the experience and efficacy of rapamycin-eluting stents in the treatment of in-stent restenosis. Methods: Nine patients who were angiographically diagnosed as having in-stent restenosis were implanted 12 rapamycin-eluting stents, 4 in the right coronary,7 in the left anterior descending, and one in the left circumflex. Results: The success rate of the procedure was 100%. Clinical symptoms were obviously ameliorated in all patients,and no severe complication was found.All patients received coronary angiography 6 months after procedure and no in-stent restenosis was noted. Conclusion: Rapamycin-eluting stent implantation can be considered safe, efficacious and feasible in the treatment of in-stent restenosis.
Keywords:Stent  Restenosis  Drug-eluting stent  Rapamycin
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号